You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Claims for Patent: 6,147,095


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,147,095
Title: Method for improving the pharmacokinetics of tipranavir
Abstract:The present invention relates to a novel method for improving the pharmacokinetics of tipranavir, comprising administering to a human in need of such treatment a combination of a therapeutically effective amount of tipranavir or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of ritonavir or a pharmaceutically acceptable salt thereof.
Inventor(s): Ferry; James J. (Kalamazoo, MI), Baldwin; John R. (Portage, MI), Borin; Marie T. (Kalamazoo, MI)
Assignee: Pharmacia & Upjohn Company (Kalamazoo, MI)
Application Number:09/430,742
Patent Claims: 1. A method for improving the pharmacokinetics of tipranavir, comprising administering to a human in need of such treatment a combination of a therapeutically effective amount of tipranavir or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of ritonavir or a pharmaceutically acceptable salt thereof.

2. The method of claim 1, wherein said therapeutically effective amount of tipranavir is between about 200 mg and about 6750 mg of tipranavir, and said therapeutically effective amount of ritonavir is between about 30 mg and about 1000 mg of ritonavir.

3. The method of claim 1, wherein said therapeutically effective amount of tipranavir is between about 200 and about 900 mg of tipranavir, and said therapeutically effective amount of ritonavir is between about 30 and about 500 mg of ritonavir.

4. The method of claim 1, wherein said therapeutically effective amount of tipranavir is between about 200 and about 900 mg of tipranavir, and said therapeutically effective amount of ritonavir is between about 30 and about 300 mg of ritonavir.

5. The method of claim 1, wherein said therapeutically effective amount of tipranavir is between about 200 and about 600 mg of tipranavir, and said therapeutically effective amount of ritonavir is between about 30 and about 500 mg of ritonavir.

6. The method of claim 1, wherein said therapeutically effective amount of tipranavir is between about 200 and about 600 mg of tipranavir, and said therapeutically effective amount of ritonavir is between about 30 and about 300 mg of ritonavir.

7. The method of claim 1, wherein said therapeutically effective amount of tipranavir is between about 200 and about 600 mg of tipranavir, and said therapeutically effective amount of ritonavir is between about 30 and about 100 mg of ritonavir.

8. A method for increasing human blood levels of tipranavir, comprising administering to a human in need of such treatment a combination of a therapeutically effective amount of tipranavir or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of ritonavir or a pharmaceutically acceptable salt thereof.

9. The method of claim 8, wherein said therapeutically effective amount of tipranavir is between about 200 mg and about 6750 mg of tipranavir, and said therapeutically effective amount of ritonavir is between about 30 mg and about 1000 mg of ritonavir.

10. The method of claim 8, wherein said therapeutically effective amount of tipranavir is between about 200 and about 900 mg of tipranavir, and said therapeutically effective amount of ritonavir is between about 30 and about 500 mg of ritonavir.

11. The method of claim 8, wherein said therapeutically effective amount of tipranavir is between about 200 and about 900 mg of tipranavir, and said therapeutically effective amount of ritonavir is between about 30 and about 300 mg of ritonavir.

12. The method of claim 8, wherein said therapeutically effective amount of tipranavir is between about 200 and about 600 mg of tipranavir, and said therapeutically effective amount of ritonavir is between about 30 and about 500 mg of ritonavir.

13. The method of claim 8, wherein said therapeutically effective amount of tipranavir is between about 200 and about 600 mg of tipranavir, and said therapeutically effective amount of ritonavir is between about 30 and about 300 mg of ritonavir.

14. The method of claim 8, wherein said therapeutically effective amount of tipranavir is between about 200 and about 600 mg of tipranavir, and said therapeutically effective amount of ritonavir is between about 30 and about 100 mg of ritonavir.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.